Jude A Oben

Hepatology — St Thomas' Hospital, United Kingdom

LeadR Profile

Jude A Oben St Thomas' Hospital United Kingdom
462 ScienceLeadR Reputation 462
Network Map

Hepatology

Subspecialties: Gastroenterology

Full career Last 3 years

Main Topics

Publications and Clinical Studies

Publications Clinical Studies

Short Biography

Leading healthcare innovation, I am an elected member of SigmaXi - An International Scientific Research Honour Society. More than 200 Nobel Prize winners have been members.https://sigmaxi.org/about. I am a Consultant Gastroenterologist-Hepatologist at Guy's and St Thomas'​ NHS Foundation Trust, with a parallel academic role as a Professor Associate in Experimental Hepatology at King's College London. My expertise in liver diseases, coupled with a steadfast commitment to medical education and research, has positioned me at the forefront of Hepatology and Metabolic Health Disease. My work is driven by a passion to understand and combat liver conditions, which has led to significant contributions in medical research, particularly in the realms of diabetic and obesity-related liver diseases. Collaboratively, my teams have advanced the knowledge of the autonomic nervous system's role in liver repair; trans-generational transmission of obesity and obesity-related liver disease; to influence public health policies and heighten societal awareness about the impact of obesity on health. https://www.linkedin.com/posts/jude-a-oben-md-phd-frcp-agaf-faasld-89a399229_widening-waistbands-are-a-burden-on-britain-activity-7252265316943036417--P4a/?utm_source=share&utm_medium=member_desktop

Organizations

Source: Pubmed

St Thomas' Hospital

Publications Synthesis

Source: Pubmed

Number : 119

Citations

Citations: 7 270 1st author: 12 Last author: 48 Unique author: 2

Main journals

Gut 13
J Hepatol 12
Hepatology 9
Biochem Biophys Res Commun 6
Gastroenterology 4

Best Journals

J Hepatol 1
Lancet Gastroenterol Hepatol 1
N Engl J Med 1

Breakdown by type

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis.
receptors, angiotensin, crohn disease, fibrosis, losartan, renin, angiotensins, angiotensin receptor antagonists, ileitis, inflammatory bowel diseases, fibroblasts, therapeutics, steroids, renin-angiotensin system
J Crohns Colitis20250
Prevalence of skin fungi markedly declines in the lesions of two patients with moderate hidradenitis suppurativa.
skin, genes, genes, rrna, mycobiome, hidradenitis suppurativa, hidradenitis, prevalence, fungi, wounds and injuries
Microb Pathog20250
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.
gastroenterology, cells, cell death, safety, organoids, acute-on-chronic liver failure
Gut20245
The British Association for the Study of the Liver commitment to equality, diversity, and inclusivity.
gastrointestinal diseases, liver diseases
Lancet Gastroenterol Hepatol Top journal20230
Metabolic endoscopy and a simplified low-carbohydrate-high-dietary fiber template as novel treatments for hidradenitis suppurativa - A case series.
carbohydrates, endoscopy, therapeutics, dietary fiber, hidradenitis suppurativa, obesity
JAAD Case Rep20234

Clinical Studies 4

Source: ClinicalTrials

Synthesis

By phase:

N/A 2
Phase 2 1
Phase 3 1

By status:

Completed 2
Terminated 2

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 1
multicentricup10 2

Main Topics

Digestive System Diseases 4

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials